Cerebral enhancement in MOG antibody-associated disease.

Paul ElsberndLaura CacciaguerraKarl N KreckeJohn J ChenDavid GritschA Sebastian Lopez-ChiribogaElia SechiVyanka RedenbaughPadraig P MorrisJonathan L CarterDean M WingerchukJan-Mendelt TillemaCristina Valencia SanchezSmathorn ThakolwiboonSean J Pittock Eoin Patrick Flanagan

Published in: Journal of neurology, neurosurgery, and psychiatry (2023)

Enhancement is common with MOGAD cerebral attacks and often has a non-specific patchy appearance and rarely persists beyond 3 months. Leptomeningeal enhancement favours MOGAD over AQP4+NMOSD and MS.

Keyphrases

subarachnoid hemorrhage
mass spectrometry
multiple sclerosis
ms ms
cerebral ischemia
cerebrospinal fluid
brain injury